Covid vaccine: US trial of AstraZeneca jab confirms safety
AstraZeneca vaccine 79% effective with no increased blood clot risk – US trial.
Study of over 32,000 people included review of risks of cerebral venous sinus thrombosis.
AstraZeneca vaccine 79% effective with no increased blood clot risk – US trial.
Study of over 32,000 people included review of risks of cerebral venous sinus thrombosis.